NCT04291950Withdrawn
Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women
Epigenetics of Triple-Negative Breast Cancer in Overweight and Obese Hispanic and Non-Hispanic White Women
Source: ClinicalTrials.gov · Last updated 20 Dec 2022
Reason given: Principal investigator is moving to a new institution. Study is closing.
Brief summary (registry, in English)
A key tenet of this project is that of reaching translational human diagnosis and biomarker end points. To lay a foundation and make progress towards these translational goals, investigators will address the following specific aim: To determine if BMI/ obesity differentially influence expression and epigenetic signatures in triple negative breast cancer (TNBC) from Hispanic compared to NHW women.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 27 Feb 2020
- Start date
- 30 Aug 2022
- Primary completion date
- 30 Aug 2025
- Lead sponsor
- University of Arizona
- Diseases
- Triple-negative breast cancer, Obesity
- NCT number
- NCT04291950
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have already undergone radiation or chemotherapy
Other illness
- Family history of breast cancer in a first-degree relative and have NOT had genetic testing for BRCA1/2
Other
- BRCA1/2 mutation carriers
- Pregnant women
- Male
- Prisoners
Who the study is looking for
- Hispanic or NHW women
- ≥ 18 years of age
- scheduled for a breast procedure as standard of care treatment - benign breast surgery or prophylactic mastectomy\
- Newly diagnosed TNBC - Patients with TNBC will be eligible regardless of whether their treatment plan is surgery first or chemotherapy first (neoadjuvant chemotherapy)
- Eligible non-white women could be included
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Arizona Cancer Center | Tucson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.